Search for Clinical Trial Results

Sponsored By

Heart Septal Defects, Atrial - 11 Studies Found

Status Study
Recruiting Study Name: Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
Condition:
  • Atrial Septal Defect
  • Successful Device Closure

Date: 2014-03-25
Interventions: Device: Transcatheter device closure Closure of atrial sep
Recruiting Study Name: A Prospective Investigation of Pleth Variability Index (PVI) as a Dynamic Parameter of Fluid Responsiveness in Children
Condition: Atrial Septal Defect
Date: 2014-10-23
Interventions: Procedure: Volume expansion Fluid bolus of 0.9% normal saline 10 mL/kg over 10 minutes
Completed Study Name: Safety and Effectiveness Study of the Solysafe Septal Occluder
Condition: Atrial Septal Defects
Date: 2006-07-16
Interventions: Device: Device Closure of a Septal Defect
Recruiting Study Name: MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure
Condition:
  • Mitral Valve Insufficiency
  • Heart Septal Defects, Atrial
    • Date: 2016-12-29
    Interventions: Device: Figulla Flex Occluder (Occlutech) Interventional closure of the iASD with an Figulla Flex Occlud
Recruiting Study Name: Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography
Condition:
  • Heart Valve Disease
  • Heart Septal Defects, Atrial

Date: 2016-06-30
Interventions:
  • Drug: Dexmedetomidine drug for
Terminated Study Name: ESCAPE Migraine Trial
Condition:
  • Migraine Disorders
  • Heart Septal Defects, Atrial

Date: 2005-12-16
Interventions:
  • Device: PFO Closure with Premere investigational device.

Recruiting Study Name: The Effect on EPCs by Successful Cardiac Occlusion Device Implantation
Condition:
  • Foramen Ovale, Patent
  • Heart Septal Defects, Atrial
  • Date: 2016-10-20
    Interventions: Other: Blood samples Blood samples at baseline and 3 timepoints for EPC analysis
Recruiting Study Name: Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure
Condition: Thrombosis
Date: 2010-03-08
Interventions: Drug: Low molecular weight heparin Low molecular weight he
Active, not recruiting Study Name: Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects
Condition: Migraine
Date: 2008-11-26
Interventions: Drug: Clopidogrel Patients will be randomized either to aspirin (80 mg/day) or aspirin (80 mg/day) + clo
Recruiting Study Name: Hyperion™ International Registry Trial
Condition:
  • Atrial Septal Defects
  • Patent Ductus Arteriosus

Date: 2014-08-14
Interventions: Device: ASD and PDA closure
Next >>>